Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Collection Sites Achieves Expansion into State of Pennsylvania with Launch of 5 New COVID-19 .
Medivolve Inc.January 14, 2021 GMT
The continued success of Collection Sites rollout has led to the expansion into Pennsylvania, with 5 sites now operating across the state for a total of 40 operating sites.
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:34C1) is pleased to announce the launch of five new COVID-19 testing centres in Pennsylvania by its wholly owned subsidiary, Collection Sites, LLC. With individual sites currently achieving strong sales with 7-day rolling average of 75 tests per day and average test price exceeding US$95 per test, these five sites are expected to add substantively to Medivolve’s top-line revenue.
Stem, Inc Awarded Project to Deliver Smart Energy Storage to Massachusetts Water Resource Authority – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stem, Inc. Awarded Project to Deliver Smart Energy Storage to Massachusetts Water Resource Authority
Stem, Inc.January 13, 2021 GMT
MILLBRAE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) Stem, Inc. (“Stem” or “the Company”), a global leader in artificial intelligence (AI)-driven energy storage systems, today announced the Company has been awarded a project mandate to provide energy storage solutions to the Massachusetts Water Resources Authority ( MWRA ) in Greater Boston, a public agency that provides wholesale water and sewer services reaching more than 3 million people in eastern and central Massachusetts. The project adds to Stem’s significant portfolio of more than 85 megawatt hours (MWh) of water treatment facilities contracted or managed by Athena™, Stem’s AI-powered smart storage software.
Search jobs AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development
SAN DIEGO (BUSINESS WIRE) AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, today announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development.
Using its novel yeast display system and large diverse human antibody libraries, AvantGen has identified a panel of high affinity human monoclonal antibody clones that bind to two distinct epitopes on the receptor binding domain of the SARS-CoV-2 spike protein. Upon binding, the antibodies block the spike protein from interacting with ACE2 and thereby prevent virus-induced cell-killing, also known as cytopathic effect. In addition, one group of antibody clones can also block ACE2’s interaction with SA
Share:
TORONTO, Jan. 12, 2021 /CNW/ - First Cobalt Corp. (TSXV:FCC) (OTCQX:FTSSF) (the Company ) is pleased to announce long-term cobalt hydroxide feed arrangements with Glencore AG and IXM SA, a fully owned subsidiary of CMOC, which will provide a total of 4,500 tonnes of contained cobalt per year to the First Cobalt Refinery commencing in 2022. Once operational, the First Cobalt Refinery will be North America s only producer of cobalt sulfate for the electric vehicle market.
Highlights
4,500 tonnes per year of contained cobalt to be provided from Glencore s KCC mine and CMOC s Tenke Fungurume mine
Supply agreements represent 90% of projected capacity for the Canadian refinery, yielding 22,250 tonnes per year of battery grade cobalt sulfate
vimarsana © 2020. All Rights Reserved.